NSN 6505-01-366-3202 · NIIN 013663202 · FSC 6505
NO DASHES 6505013663202
In Stock
ALTEPLASE FOR INJECTION
Drugs and Biologicals
Technical characteristics
7 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AGXW | PHYSICAL FORM | FREEZE-DRIED POWDER |
| CBBL | FEATURES PROVIDED | THINNER AND STERILE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | INTERNATIONAL UNITS OF ACTIVE INGREDIENT 58000000.000 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ALTEPLASE FOR INJECTION 100 MG (58 MILLION I.U) |
| FEAT | SPECIAL FEATURES | 58 MILLION I.U. OF ALTEPLASE EQUIV. PER 100 MG; ALSO CONTAINS 3.5 GRAMS L-ARGININE,1 GRAM PHOSPHORIC ACID,AND LESS THAN 11 MG POLYSORBATE 80; RECOMBINANT; W/ONE 100 ML VIAL OF STERILE WATER FOR INJECTION,USP AND ONE TRANSFER DEVICE; FOR USE AS A THROMBOLYTIC AGENT |